$11.4 Billion is the total value of IRIDIAN ASSET MANAGEMENT LLC/CT's 78 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALEX | Exit | ALEXANDER & BALDWIN INC | $0 | – | -20,000 | -100.0% | -0.01% | – |
| LLY | Exit | ELI LILLY & CO | $0 | – | -10,000 | -100.0% | -0.01% | – |
| STAY | Exit | EXTENDED STAY AMERICA INCcall | $0 | – | -60,200 | -100.0% | -0.01% | – |
| RRMS | Exit | ROSE ROCK MIDSTREAM LP | $0 | – | -68,279 | -100.0% | -0.02% | – |
| TXN | Exit | TEXAS INSTRUMENTS INC | $0 | – | -35,000 | -100.0% | -0.02% | – |
| LXK | Exit | LEXMARK INTERNATIONAL INC | $0 | – | -1,202,171 | -100.0% | -0.42% | – |
| MYGN | Exit | MYRIAD GENETICS INC. | $0 | – | -3,215,862 | -100.0% | -0.91% | – |
| SCI | Exit | SERVICE CORP INTERNATIONAL/US | $0 | – | -4,060,376 | -100.0% | -1.02% | – |
| HTZ | Exit | HERTZ GLOBAL HOLDINGS | $0 | – | -14,988,648 | -100.0% | -1.54% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- BMO ASSET MANAGEMENT CORP. #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-09
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| WYNDHAM WORLDWIDE CORP | 31 | Q4 2020 | 4.8% |
| WR GRACE & CO | 30 | Q3 2020 | 5.0% |
| VISTEON CORP | 30 | Q3 2021 | 2.9% |
| POST HOLDINGS INC. | 29 | Q3 2023 | 5.4% |
| LABORATORY CORP OF AMERICA HOLDINGS | 29 | Q3 2023 | 4.7% |
| UNIVAR USA INC | 29 | Q2 2023 | 4.6% |
| HALOZYME THERAPEUTICS INC | 29 | Q3 2020 | 1.8% |
| FLEXTRONICS INTL LTD | 27 | Q3 2023 | 5.1% |
| BALL CORPORATION | 27 | Q4 2022 | 3.3% |
| INTERCONTINENTAL EXCHANGE INC | 25 | Q3 2023 | 3.6% |
View IRIDIAN ASSET MANAGEMENT LLC/CT's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Axsome Therapeutics, Inc. | January 18, 2022 | ? | ? |
| Katapult Holdings, Inc. | January 18, 2022 | ? | ? |
| Travel & Leisure Co. | January 18, 2022 | ? | ? |
| Chemours Co | January 28, 2020 | ? | ? |
| HALOZYME THERAPEUTICS, INC. | January 28, 2020 | ? | ? |
| MEDICINES CO /DE | January 28, 2020 | ? | ? |
| Univar Solutions Inc. | January 28, 2020 | ? | ? |
| VISTEON CORP | November 04, 2019 | ? | ? |
| ALLEGHENY TECHNOLOGIES INC | February 06, 2019 | ? | ? |
| ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. | February 06, 2019 | ? | ? |
View IRIDIAN ASSET MANAGEMENT LLC/CT's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-01 |
| 13F-HR | 2024-01-26 |
| SC 13G/A | 2024-01-24 |
| 13F-HR | 2023-10-30 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-04-28 |
| SC 13G | 2023-02-03 |
| 13F-HR | 2023-01-31 |
| 13F-HR | 2022-11-07 |
| 13F-HR | 2022-07-29 |
View IRIDIAN ASSET MANAGEMENT LLC/CT's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.